158 related articles for article (PubMed ID: 9770712)
1. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
Oexle C; Reinhardt M; Moser E
Nuklearmedizin; 1998; 37(6):192-6. PubMed ID: 9770712
[TBL] [Abstract][Full Text] [Related]
2. [Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy].
Dunkelmann S; Endlicher D; Prillwitz A; Rudolph F; Groth P; Schümichen C
Nuklearmedizin; 1999; 38(5):131-9. PubMed ID: 10488479
[TBL] [Abstract][Full Text] [Related]
3. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
Meller J; Wisheu S; Munzel U; Behe M; Gratz S; Becker W
Eur J Nucl Med; 2000 Sep; 27(9):1286-91. PubMed ID: 11007508
[TBL] [Abstract][Full Text] [Related]
5. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
Reinhardt M; Emrich D; Krause T; Bräutigam P; Nitzsche E; Blattmann H; Schümichen C; Moser E
Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
[TBL] [Abstract][Full Text] [Related]
6. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
7. TcTU before and after exogeneous TSH suppression in diagnosing thyroid autonomy.
Kreisig T; Pickardt CR; Kirsch CM; Knesewitsch P
Acta Med Austriaca; 1990; 17 Suppl 1():54-5. PubMed ID: 2167603
[TBL] [Abstract][Full Text] [Related]
8. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Gotthardt M; Rubner C; Bauhofer A; Berce F; Oyen WJ; Goecke J; Pfestroff A; Schlieck A; Corstens FH; Béhé M; Behr TM
Nuklearmedizin; 2006; 45(5):206-12. PubMed ID: 17043731
[TBL] [Abstract][Full Text] [Related]
9. Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
Reinhardt MJ; Biermann K; Wissmeyer M; Juengling FD; Brockmann H; von Mallek D; Ezziddin S; Joe AY; Krause TM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):608-12. PubMed ID: 16541268
[TBL] [Abstract][Full Text] [Related]
10. [Change of 99m technetium-pertechnetate uptake by the thyroid under suppression (TcTus) induced by optimization of iodine supply in Germany].
Reinhardt MJ; Trupkovic T; Schumacher T; Krause TM; Oexle C; Moser E
Nuklearmedizin; 1998; 37(6):202-7. PubMed ID: 9770714
[TBL] [Abstract][Full Text] [Related]
11. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
Seeger T; Emrich D; Sandrock D
Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
13. Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy.
Gotthardt M; Stübinger M; Pansegrau J; Buchwald B; Goecke J; Pfestroff A; Corstens FH; Behr TM
Nuklearmedizin; 2006; 45(3):122-5. PubMed ID: 16710508
[TBL] [Abstract][Full Text] [Related]
14. Separation of autonomous function from cell density in non-immunogenic hyperthyroidism--II. quantified comparison before and after radioiodine therapy.
Als C; Rösler H; Listewnik M
Nuklearmedizin; 1996 Feb; 35(1):12-9. PubMed ID: 8746167
[TBL] [Abstract][Full Text] [Related]
15. Negative correlation between therapeutic success in radioiodine therapy and TcTUs: are TcTUs-adapted dose concepts the only possible answer?
Gotthardt M; Nowack M; Béhé MP; Schipper ML; Schlieck A; Höffken H; Behr TM
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1165-8. PubMed ID: 12827311
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic evaluation of functional thyroidal autonomy.
Meller J; Becker W
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S45-51. PubMed ID: 9867196
[TBL] [Abstract][Full Text] [Related]
17. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism.
Giovanella L; Ceriani L; Ghelfo A
Horm Metab Res; 2008 Jul; 40(7):484-6. PubMed ID: 18393171
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
[TBL] [Abstract][Full Text] [Related]
19. Separation of autonomous function from cell density in non-immunogenic hyperthyroidism. I. Quantification by double-isotope parametric scintigraphy.
Als C; Listevnik M; Rösler H; Ritter EP
Nuklearmedizin; 1995 Dec; 34(6):215-22. PubMed ID: 8596737
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
